» Articles » PMID: 3221006

Treatment of Hypertensive Crisis in Children with Nifedipine

Overview
Specialty Critical Care
Date 1988 Jan 1
PMID 3221006
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

We report 31 episodes of hypertensive crises in children, managed with sublingual nifedipine at the following dosages: 10 mg in children with body weight (BW) higher than 20 kg, 5 mg in children with BW between 10 and 20 kg, and 2.5 mg in children with BW below 10 kg. The mean initial blood pressures were 161.41 mm Hg for the systolic pressure (mSBP) and 111.25 mm Hg for the diastolic pressure (mDBP). After nifedipine, both the mSBP and the mDBP decreased, with onset of effect five minutes after dosage and maximum decrease at 60 min (mSBP 134.93 mm Hg, mDBP 79.23 mm Hg, for decreases of 16.4 and 28.7%, respectively), and this effect persisted for 180 min. Blood pressure increased again from min 240 to min 360, yet without reaching the initial levels. One case did not respond to the first dose of nifedipine and required a second one. The effect of nifedipine was more pronounced on the DBP than on the SBP, and greater reductions of both pressures were achieved in the cases with higher initial readings. No side of medication were observed in our patients.

Citing Articles

A review of calcium channel antagonists in the treatment of pediatric hypertension.

Sahney S Paediatr Drugs. 2006; 8(6):357-73.

PMID: 17154643 DOI: 10.2165/00148581-200608060-00004.


The safety and use of short-acting nifedipine in hospitalized hypertensive children.

Yiu V, Orrbine E, Rosychuk R, MacLaine P, Goodyer P, Girardin C Pediatr Nephrol. 2004; 19(6):644-50.

PMID: 15054645 DOI: 10.1007/s00467-004-1444-x.


Comparative tolerability profile of hypertensive crisis treatments.

Grossman E, Ironi A, Messerli F Drug Saf. 1998; 19(2):99-122.

PMID: 9704248 DOI: 10.2165/00002018-199819020-00003.


Clinical pharmacokinetics of vasodilators. Part I.

Kirsten R, Nelson K, Kirsten D, Heintz B Clin Pharmacokinet. 1998; 34(6):457-82.

PMID: 9646008 DOI: 10.2165/00003088-199834060-00003.


Dosage of nifedipine in hypertensive crises of infants and children.

Lopez-Herce J, Dorao P, de la Oliva P, Delgado M, Martinez M, Ruza F Eur J Pediatr. 1989; 149(2):136-7.

PMID: 2591406 DOI: 10.1007/BF01995865.

References
1.
Guazzi M, Olivari M, Polese A, Fiorentini C, Magrini F, Moruzzi P . Nifedipine, a new antihypertensive with rapid action. Clin Pharmacol Ther. 1977; 22(5 Pt 1):528-32. DOI: 10.1002/cpt1977225part1528. View

2.
Dilmen U, Caglar M, Senses D, Kinik E . Nifedipine in hypertensive emergencies of children. Am J Dis Child. 1983; 137(12):1162-5. DOI: 10.1001/archpedi.1983.02140380022007. View

3.
Ellrodt A, Ault M, Riedinger M, Murata G . Efficacy and safety of sublingual nifedipine in hypertensive emergencies. Am J Med. 1985; 79(4A):19-25. DOI: 10.1016/0002-9343(85)90496-6. View

4.
Davidson R, Bursten S, Keeley P, Kenny M, STEWART D . Oral nifedipine for the treatment of patients with severe hypertension. Am J Med. 1985; 79(4A):26-30. DOI: 10.1016/0002-9343(85)90497-8. View

5.
Aoki K, Kondo S, Mochizuki A, Yoshida T, Kato S, Kato K . Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade. Am Heart J. 1978; 96(2):218-26. DOI: 10.1016/0002-8703(78)90089-3. View